DE602004024584D1 - Inhibitoren der nicht-nukleotidischen reversen transkriptase - Google Patents
Inhibitoren der nicht-nukleotidischen reversen transkriptaseInfo
- Publication number
- DE602004024584D1 DE602004024584D1 DE602004024584T DE602004024584T DE602004024584D1 DE 602004024584 D1 DE602004024584 D1 DE 602004024584D1 DE 602004024584 T DE602004024584 T DE 602004024584T DE 602004024584 T DE602004024584 T DE 602004024584T DE 602004024584 D1 DE602004024584 D1 DE 602004024584D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- orx
- nrxrx
- nucleotidic
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102100034343 Integrase Human genes 0.000 title 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 229940121357 antivirals Drugs 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400021A SE0400021D0 (sv) | 2004-01-08 | 2004-01-08 | Non-nucleoside reverse transcriptase inhibitors |
| SE0400585A SE0400585D0 (sv) | 2004-03-09 | 2004-03-09 | NNRTI Antivirals |
| PCT/SE2004/002034 WO2005066131A1 (en) | 2004-01-08 | 2004-12-30 | Non-nucleotide reverse transcriptase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004024584D1 true DE602004024584D1 (de) | 2010-01-21 |
Family
ID=34752289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004024584T Active DE602004024584D1 (de) | 2004-01-08 | 2004-12-30 | Inhibitoren der nicht-nukleotidischen reversen transkriptase |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7915295B2 (de) |
| EP (1) | EP1701942B1 (de) |
| JP (1) | JP4762917B2 (de) |
| AT (1) | ATE451357T1 (de) |
| AU (1) | AU2004312284B2 (de) |
| BR (1) | BRPI0418306B8 (de) |
| CA (1) | CA2550187C (de) |
| DE (1) | DE602004024584D1 (de) |
| DK (1) | DK1701942T3 (de) |
| EA (1) | EA009700B1 (de) |
| ES (1) | ES2337794T3 (de) |
| HK (1) | HK1101400A1 (de) |
| IL (1) | IL176740A (de) |
| NZ (1) | NZ548367A (de) |
| SG (1) | SG149070A1 (de) |
| WO (1) | WO2005066131A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005538155A (ja) * | 2002-09-05 | 2005-12-15 | メディヴィル・アクチボラグ | 非ヌクレオシド逆転写酵素インヒビター |
| US7388008B2 (en) | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
| CA2606025A1 (en) * | 2005-04-27 | 2006-11-02 | Ambrilia Biopharma Inc. | Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors |
| CA2632095A1 (en) | 2005-11-30 | 2007-06-07 | Ambrilia Biopharma Inc. | Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
| GB0608876D0 (en) | 2006-05-05 | 2006-06-14 | Medivir Ab | Combination therapy |
| EP2021327B1 (de) * | 2006-05-15 | 2012-04-04 | Merck Sharp & Dohme Corp. | Antidiabetische bicyclische verbindungen |
| AU2007337830A1 (en) | 2006-09-21 | 2008-07-03 | Ambrilia Biopharma Inc. | Benzenesulfonamide derivatives as HIV protease inhibitors |
| CN107438593B (zh) * | 2015-01-30 | 2020-10-30 | 基因泰克公司 | 治疗化合物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4488621B2 (ja) | 1998-01-16 | 2010-06-23 | メディヴィル・アクチボラグ | 抗ウイルス剤 |
| WO1999051613A1 (en) | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
| SE0100733D0 (sv) * | 2001-03-05 | 2001-03-05 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
| SE0102867D0 (sv) | 2001-08-28 | 2001-08-28 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
| JP2005538155A (ja) | 2002-09-05 | 2005-12-15 | メディヴィル・アクチボラグ | 非ヌクレオシド逆転写酵素インヒビター |
-
2004
- 2004-12-30 NZ NZ548367A patent/NZ548367A/en not_active IP Right Cessation
- 2004-12-30 AT AT04809207T patent/ATE451357T1/de not_active IP Right Cessation
- 2004-12-30 WO PCT/SE2004/002034 patent/WO2005066131A1/en active Application Filing
- 2004-12-30 CA CA2550187A patent/CA2550187C/en not_active Expired - Fee Related
- 2004-12-30 EA EA200601289A patent/EA009700B1/ru not_active IP Right Cessation
- 2004-12-30 BR BRPI0418306A patent/BRPI0418306B8/pt not_active IP Right Cessation
- 2004-12-30 DE DE602004024584T patent/DE602004024584D1/de active Active
- 2004-12-30 SG SG200809639-8A patent/SG149070A1/en unknown
- 2004-12-30 DK DK04809207.6T patent/DK1701942T3/da active
- 2004-12-30 US US10/584,933 patent/US7915295B2/en not_active Expired - Fee Related
- 2004-12-30 JP JP2006549182A patent/JP4762917B2/ja not_active Expired - Fee Related
- 2004-12-30 ES ES04809207T patent/ES2337794T3/es active Active
- 2004-12-30 EP EP04809207A patent/EP1701942B1/de active Active
- 2004-12-30 AU AU2004312284A patent/AU2004312284B2/en not_active Ceased
-
2006
- 2006-07-06 IL IL176740A patent/IL176740A/en not_active IP Right Cessation
-
2007
- 2007-08-29 HK HK07109407.1A patent/HK1101400A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007519640A (ja) | 2007-07-19 |
| IL176740A0 (en) | 2006-10-31 |
| BRPI0418306A (pt) | 2007-05-02 |
| SG149070A1 (en) | 2009-01-29 |
| BRPI0418306B8 (pt) | 2021-05-25 |
| EA200601289A1 (ru) | 2006-12-29 |
| ES2337794T3 (es) | 2010-04-29 |
| ATE451357T1 (de) | 2009-12-15 |
| AU2004312284B2 (en) | 2010-08-05 |
| EA009700B1 (ru) | 2008-02-28 |
| US7915295B2 (en) | 2011-03-29 |
| EP1701942B1 (de) | 2009-12-09 |
| IL176740A (en) | 2011-09-27 |
| NZ548367A (en) | 2010-06-25 |
| CA2550187C (en) | 2012-08-07 |
| JP4762917B2 (ja) | 2011-08-31 |
| HK1101400A1 (en) | 2007-10-18 |
| BRPI0418306B1 (pt) | 2018-09-18 |
| CA2550187A1 (en) | 2005-07-21 |
| US20080070951A1 (en) | 2008-03-20 |
| AU2004312284A2 (en) | 2005-07-21 |
| WO2005066131A1 (en) | 2005-07-21 |
| EP1701942A1 (de) | 2006-09-20 |
| AU2004312284A1 (en) | 2005-07-21 |
| DK1701942T3 (da) | 2010-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1101400A1 (en) | Non-nucleotide reverse transcriptase inhibitors | |
| EA200602060A1 (ru) | Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы | |
| MY138941A (en) | Aryl-pyridine derivatives | |
| RS53569B1 (en) | NEW COMPOUNDS AND COMPOSITIONS, AND PROCEDURES FOR USE | |
| NZ596615A (en) | Substituted isoquinoline derivative | |
| CY1111310T1 (el) | Ενωσεις για την αγωγη μεταβολικων διαταραχων | |
| EA201591000A1 (ru) | Пирролобензодиазепины | |
| BRPI0518068A (pt) | composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada | |
| DE602006009080D1 (de) | 1-essigsäureindolderivate mit pgd2-antagonistischer wirkung | |
| NO20080738L (no) | Fremgangsmater for neurobeskyttelse | |
| WO2008108386A1 (ja) | 医薬組成物 | |
| EA200000731A1 (ru) | Альфа-аминоамидные производные, полезные в качестве анальгетических агентов | |
| RS51674B (en) | PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS | |
| CO5690608A2 (es) | 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogena cronica | |
| MX2014004144A (es) | Derivados de etinilo como moduladores alostericos del receptor de glutamato metabotropico del subtipo 5 (mglur5). | |
| MX2010003224A (es) | Derivados de biaril sulfonamida. | |
| ATE94061T1 (de) | Arylsubstituierte aminderivate verwendbar in der krebstherapie. | |
| JP2010527915A5 (de) | ||
| EA200970793A1 (ru) | Модуляторы рецепторов, активируемых пролифераторами пероксисом | |
| BRPI0607407A2 (pt) | derivados de mentano carboxamida tendo propriedades de refrescáncia | |
| EA201070010A1 (ru) | Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии | |
| WO2008078445A1 (ja) | 重合性化合物及び重合性組成物 | |
| MY140666A (en) | Biotinylated hexadecasaccharides, preparation and use thereof | |
| JP2012006843A5 (de) | ||
| EA201101298A1 (ru) | Аддитивные соли трометамина с производными азабифениламинобензойной кислоты в качестве ингибиторов dhodh |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |